• 2011
    • van Loon, R. L. E., Roofthooft, M. T. R., Hillege, H. L., ten Harkel, A. D. J., van Osch-Gevers, M., Delhaas, T., Kapusta, L., Strengers, J. L. M., Rammeloo, L. A. J., Clur, S.-A. B., Mulder, B. J. M., & Berger, R. M. F. (2011). Pediatric Pulmonary Hypertension in the Netherlands Epidemiology and Characterization During the Period 1991 to 2005. Circulation, 124(16), 1755-U136. https://doi.org/10.1161/CIRCULATIONAHA.110.969584
    • Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., van Veldhuisen, D. J., Ranchor, A. V., & Van Gelder, I. C. (2011). The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study. Journal of the American College of Cardiology, 58(17), 1795-1803. https://doi.org/10.1016/j.jacc.2011.06.055
    • International Consortium for Blood Pressure Genome-Wide Association Studies (2011). Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478(7367), 103-109. https://doi.org/10.1038/nature10405
    • Soehnlein, O., Wantha, S., Simsekyilmaz, S., Doering, Y., Megens, R. T. A., Mause, S. F., Drechsler, M., Smeets, R., Weinandy, S., Schreiber, F., Gries, T., Jockenhoevel, S., Moeller, M., Vijayan, S., van Zandvoort, M. A. M. J., Agerberth, B., Pham, C. C. T. N., Gallo, R. L., Hackeng, T. M., ... Weber, C. (2011). Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia. Science Translational Medicine, 3(103), 10. https://doi.org/10.1126/scitranslmed.3002531
    • Surakka, I., Isaacs, A., Karssen, L. C., Laurila, P.-P. P., Middelberg, R. P. S., Tikkanen, E., Ried, J. S., Lamina, C., Mangino, M., Igl, W., Hottenga, J.-J., Lagou, V., van der Harst, P., Mateo Leach, I., Esko, T., Kutalik, Z., Wainwright, N. W., Struchalin, M. V., Sarin, A.-P., ... ENGAGE Consortium (2011). A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol. Plos Genetics, 7(10), e1002333. https://doi.org/10.1371/journal.pgen.1002333
    • Bogaard, M. D., Houthuizen, P., Bracke, F. A., Doevendans, P. A., Prinzen, F. W., Meine, M., & van Gelder, B. M. (2011). Baseline left ventricular dP/dt(max) rather than the acute improvement in dP/dt(max) predicts clinical outcome in patients with cardiac resynchronization therapy. European journal of heart failure, 13(10), 1126-1132. https://doi.org/10.1093/eurjhf/hfr094
    • Weijs, B., Blaauw, Y., Rennenberg, R. J. M. W., Schurgers, L. J., Timmermans, C. C. M. M., Pison, L., Nieuwlaat, R., Hofstra, L., Kroon, A. A., Wildberger, J., & Crijns, H. J. G. M. (2011). Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. European Heart Journal, 32(20), 2555-2562. https://doi.org/10.1093/eurheartj/ehr226
    • Heinis, A. M. F., Spaanderman, M. E., Gunnewiek, J. M. T. K., & Lotgering, F. K. (2011). Scalp blood lactate for intra-partum assessment of fetal metabolic acidosis. Acta Obstetricia et Gynecologica Scandinavica, 90(10), 1107-1114. https://doi.org/10.1111/j.1600-0412.2011.01237.x
    • Bis, J. C., Kavousi, M., Franceschini, N., Isaacs, A., Abecasis, G. R., Schminke, U., Post, W. S., Smith, A. V., Cupples, L. A., Markus, H. S., Schmidt, R., Huffman, J. E., Lehtimäki, T., Baumert, J., Münzel, T., Heckbert, S. R., Dehghan, A., North, K., Oostra, B., ... CARDIoGRAM Consortium (2011). Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nature Genetics, 43(10), 940-7. https://doi.org/10.1038/ng.920
    • Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., & Casadei, B. (2011). Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation Implications for the Antiarrhythmic Effect of Statins. Circulation, 124(10), 1107-U91. https://doi.org/10.1161/CIRCULATIONAHA.111.029223
    • Lim, A. C., Schuit, E., Bloemenkamp, K., Bernardus, R. E., Duvekot, J. J., Erwich, J. J. H. M., van Eyck, J., Groenwold, R. H. H., Hasaart, T. H. M., Hummel, P., Kars, M. M., Kwee, A., van Oirschot, C. M., van Pampus, M. G., Papatsonis, D. N. M., Porath, M., Spaanderman, M. E., Willekes, C., Wilpshaar, J., ... Bruinse, H. W. (2011). 17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies. Obstetrics and Gynecology, 118(3), 513-520. https://doi.org/10.1097/AOG.0b013e31822ad6aa
    • Schuur, M., Ikram, M. A., van Swieten, J. C., Isaacs, A., Vergeer-Drop, J. M., Hofman, A., Oostra, B. A., Breteler, M. M. B., & van Duijn, C. M. (2011). Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis. Neurobiology of Aging, 32(9), 1607-14. https://doi.org/10.1016/j.neurobiolaging.2009.10.011
    • Linz, D., Schotten, U., Neuberger, H.-R., Boehm, M., & Wirth, K. (2011). Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm, 8(9), 1436-1443. https://doi.org/10.1016/j.hrthm.2011.03.053
    • Heemstra, H. E., Nieuwlaat, R., Meijboom, M., & Crijns, H. J. (2011). The burden of atrial fibrillation in the Netherlands. Netherlands Heart Journal, 19(9), 373-378. https://doi.org/10.1007/s12471-011-0175-4
    • Kornfeld, J.-W., Isaacs, A., Vitart, V., Pospisilik, J. A., Meitinger, T., Gyllensten, U., Wilson, J. F., Rudan, I., Campbell, H., Penninger, J. M., Sexl, V., Moriggl, R., van Duijn, C., Pramstaller, P. P., & Hicks, A. A. (2011). Variants in STAT5B associate with serum TC and LDL-C levels. Journal of Clinical Endocrinology & Metabolism, 96(9), E1496-501. https://doi.org/10.1210/jc.2011-0322
    • Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., Van den Berg, M. P., van Veldhuisen, D. J., & Van Gelder, I. C. (2011). Effect of Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 58(9), 942-949. https://doi.org/10.1016/j.jacc.2011.04.030
    • van Drongelen, J., Pertijs, J., Wouterse, A., Hermsen, R., Sweep, F. C. G. J., Lotgering, F. K., Smits, P., & Spaanderman, M. E. A. (2011). Contribution of different local vascular responses to mid-gestational vasodilation. American Journal of Obstetrics and Gynecology, 205(2), Article 155.e12. https://doi.org/10.1016/j.ajog.2011.03.020
    • Torp-Pedersen, C., Crijns, H. J. G. M., Gaudin, C., Page, R. L., Connolly, S. J., & Hohnloser, S. H. (2011). Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. EP Europace, 13(8), 1118-1126. https://doi.org/10.1093/europace/eur102
    • van den Wijngaard, A., Volders, P., van Tintelen, J. P., Jongbloed, J. D. H., van den Berg, M. P., Deprez, R. H. L., Mannens, M. M. A. M., Hofmann, N., van Slegtenhorst, M., Dooijes, D., Michels, M., Arens, Y., Jongbloed, R., & Smeets, B. J. M. (2011). Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Netherlands Heart Journal, 19(7-8), 344-351. https://doi.org/10.1007/s12471-011-0135-z
    • Camm, A. J., Breithardt, G., Crijns, H., Dorian, P., Kowey, P. R., Le Heuzey, J.-Y., Merioua, I., Pedrazzini, L., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C., & Weintraub, W. S. (2011). Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). Journal of the American College of Cardiology, 58(5), 493-501. https://doi.org/10.1016/j.jacc.2011.03.034
    • Weber, C., Meiler, S., Doering, Y., Koch, M., Drechsler, M., Megens, R. T. A., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., van Zandvoort, M. A. M. J., Binder, C. J., Jelinek, I., Hristov, M., Boon, L., Jung, S., Korn, T., Lutz, M. B., Foerster, I., ... Zernecke, A. (2011). CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. Journal of Clinical Investigation, 121(7), 2898-2910. https://doi.org/10.1172/JCI44925
    • Foley, P. W. X., Chalil, S., Ratib, K., Smith, R., Prinzen, F., Auricchio, A., & Leyva, F. (2011). Fluoroscopic Left Ventricular Lead Position and the Long-Term Clinical Outcome of Cardiac Resynchronization Therapy. Pacing and Clinical Electrophysiology, 34(7), 785-797. https://doi.org/10.1111/j.1540-8159.2011.03114.x
    • Demirkan, A., Amin, N., Isaacs, A., Jarvelin, M.-R., Whitfield, J. B., Wichmann, H.-E., Kyvik, K. O. H. M., Rudan, I., Gieger, C., Hicks, A. A., Johansson, Å., Hottenga, J.-J., Smith, J. J., Wild, S. H., Pedersen, N. L., Willemsen, G., Mangino, M., Hayward, C., Uitterlinden, A. G., ... ENGAGE Consortium (2011). Genetic architecture of circulating lipid levels. European Journal of Human Genetics, 19(7), 813-9. https://doi.org/10.1038/ejhg.2011.21
    • La Meir, M., Gelsomino, S., Luca, F., Pison, L., Chambille, P., Parise, O., Crijns, H. J., & Maessen, J. G. (2011). Time-Related Prevalence of Postoperative Atrial Fibrillation After Stand-Alone Minimally Invasive Radiofrequency Ablation. Journal of Cardiac Surgery, 26(4), 453-459. https://doi.org/10.1111/j.1540-8191.2011.01272.x
    • Cox, M. G. P. J., van der Zwaag, P. A., van der Werf, C., van der Smagt, J. J., Noorman, M., Bhuiyan, Z. A., Wiesfeld, A. C. P., Volders, P. G. A., van Langen, I. M., Atsma, D. E., Dooijes, D., van den Wijngaard, A., Houweling, A. C., Jongbloed, J. D. H., Jordaens, L. J. L. M., Cramer, M. J., Doevendans, P. A., de Bakker, J. M. T., Wilde, A. A. M., ... Hauer, R. N. W. (2011). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study. Circulation, 123(23), 2690-2700. https://doi.org/10.1161/CIRCULATIONAHA.110.988287
    • Leyva, F., Foley, P. W. X., Chalil, S., Ratib, K., Smith, R. E. A., Prinzen, F., & Auricchio, A. (2011). Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 13(1), 9. https://doi.org/10.1186/1532-429X-13-29
    • Strik, M., Ploux, S., Vernooy, K., & Prinzen, F. W. (2011). Cardiac Resynchronization Therapy - Refocus on the Electrical Substrate. Circulation Journal, 75(6), 1297-1304. https://doi.org/10.1253/circj.CJ-11-0356
    • Postema, P. G., Christiaans, I., Hofman, N., Alders, M., Koopmann, T. T., Bezzina, C. R., Loh, P., Zeppenfeld, K., Volders, P. G. A., & Wilde, A. A. M. (2011). Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Netherlands Heart Journal, 19(6), 290-296. https://doi.org/10.1007/s12471-011-0102-8
    • Laverty, H. G., Benson, C., Cartwright, E. J., Cross, M. J., Garland, C., Hammond, T. R., Holloway, C., McMahon, N., Milligan, J., Park, B. K., Pirmohamed, M., Pollard, C., Radford, J., Roome, N., Sager, P., Singh, S., Suter, T., Suter, W., Trafford, A. W., ... Valentin, J. P. (2011). How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?British Journal of Pharmacology, 163(4), 675-693. https://doi.org/10.1111/j.1476-5381.2011.01255.x
    • Zhou, Z., Subramanian, P., Sevilmis, G., Globke, B., Soehnlein, O., Karshovska, E., Megens, R., Heyll, K., Chun, J., Saulnier-Blache, J. S., Reinholz, M., van Zandvoort, M., Weber, C., & Schobert, A. (2011). Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium. Cell Metabolism, 13(5), 592-600. https://doi.org/10.1016/j.cmet.2011.02.016
    • van Geldorp, I. E., Vanagt, W. Y., Prinzen, F. W., & Delhaas, T. (2011). Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease. Heart Failure Reviews, 16(3), 305-314. https://doi.org/10.1007/s10741-010-9207-1
    • Cornelussen, R. N., Splett, V., Klepfer, R. N., Stegemann, B., Kornet, L., & Prinzen, F. W. (2011). Electrical modalities beyond pacing for the treatment of heart failure. Heart Failure Reviews, 16(3), 315-325. https://doi.org/10.1007/s10741-010-9206-2
    • Dinh, T., Baur, L. H. B., Pisters, R., Kamp, O., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Tieleman, R. G., Prins, M. H., & Crijns, H. J. G. M. (2011). Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study. Netherlands Heart Journal, 19(5), 214-222. https://doi.org/10.1007/s12471-011-0095-3
    • Megens, R. T. A., Kemmerich, K., Pyta, J., Weber, C., & Soehnlein, O. (2011). Intravital imaging of phagocyte recruitment. Thrombosis and Haemostasis, 105(5), 802-810. https://doi.org/10.1160/TH10-11-0735
    • Heijman, J., Volders, P. G. A., Westra, R. L., & Rudy, Y. (2011). Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca2+-transient. Journal of Molecular and Cellular Cardiology, 50(5), 863-871. https://doi.org/10.1016/j.yjmcc.2011.02.007
    • Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., Van den Berg, M. P., Volders, P. G. A., Arens, Y. H., van den Wijngaard, A., Atsma, D. E., Helderman-van den Enden, A. T. J. M., Houweling, A. C., de Boer, K., van der Smagt, J. J., Hauer, R. N. W., Marcelis, C. L. M., ... Wilde, A. A. M. (2011). Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. European Heart Journal, 32(9), 1161-1170. https://doi.org/10.1093/eurheartj/ehr092
    • Prinzen, F. W., Vernooy, K., DeBoeck, B. W. L., & Delhaas, T. (2011). Mechano-energetics of the asynchronous and resynchronized heart. Heart Failure Reviews, 16(3), 215-224. https://doi.org/10.1007/s10741-010-9205-3
    • Koetje, P. M., Spaan, J. J., Kooman, J. P., Spaanderman, M. E. A., & Peeters, L. L. H. (2011). Pregnancy Reduces the Accuracy of the Estimated Glomerular Filtration Rate Based on Cockroft-Gault and MDRD Formulas.Reproductive Sciences, 18(5), 456-462. https://doi.org/10.1177/1933719110387831
    • Scholten, R. R., Sep, S., Peeters, L., Hopman, M. T. E., Lotgering, F. K., & Spaanderman, M. E. A. (2011). Prepregnancy Low-Plasma Volume and Predisposition to Preeclampsia and Fetal Growth Restriction. Obstetrics and Gynecology, 117(5), 1085-1093. https://doi.org/10.1097/AOG.0b013e318213cd31
    • Page, R. L., Connolly, S. J., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Torp-Pedersen, C., & Hohnloser, S. H. (2011). Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial). American Journal of Cardiology, 107(7), 1019-1022. https://doi.org/10.1016/j.amjcard.2010.11.028
    • De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., Gavazzi, A., Sanzo, A., Dennert, R., Kuschyk, J., Raspopovic, S., Klein, H., Swedberg, K., & Schwartz, P. J. (2011). Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. European Heart Journal, 32(7), 847-855. https://doi.org/10.1093/eurheartj/ehq391
    • Alzand, B. S. N., & Crijns, H. J. G. M. (2011). Diagnostic criteria of broad QRS complex tachycardia: decades of evolution. EP Europace, 13(4), 465-472. https://doi.org/10.1093/europace/euq430
    • van Rijsingen, I. A. W., Bekkers, S. C. A. M., Schalla, S., Hermans-van Ast, J. F., Snoep, G., Alzand, B. S. N., Arens, Y. H. J. M., van den Wijngaard, A., Crijns, H. J. G. M., & Pinto, Y. M. (2011). Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers. Netherlands Heart Journal, 19(4), 168-174. https://doi.org/10.1007/s12471-011-0090-8
    • Kirchhof, P., Kahr, P. C., Kaese, S., Piccini, I., Vokshi, I., Scheld, H.-H., Rotering, H., Fortmueller, L., Laakmann, S., Verheule, S., Schotten, U., Fabritz, L., & Brown, N. A. (2011). PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression. Circulation : Cardiovascular Genetics, 4(2), 123-U84. https://doi.org/10.1161/CIRCGENETICS.110.958058
    • ACCF/AHA TASK FORCE MEMBERS, & Crijns, H. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123(10), 1144-1150. https://doi.org/10.1161/CIR.0b013e31820f14c0
    • Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, L. S., Estes, N. A. M. III., Ezekowitz, M. D., Jackman, W. M., January, C. T., Page, R. L., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 57(11), E101-E198. https://doi.org/10.1016/j.jacc.2010.09.013
    • Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M. III., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., Stevenson, W. G., Tracy, C. M., Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Halperin, J. L., Kay, G. N., Le Heuzey, J.-Y., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm, 8(3), E1-E8. https://doi.org/10.1016/j.hrthm.2011.01.032
    • Greiser, M., Lederer, W. J., & Schotten, U. (2011). Alterations of atrial Ca2+ handling as cause and consequence of atrial fibrillation. Cardiovascular Research, 89(4), 722-733. https://doi.org/10.1093/cvr/cvq389
    • Brugts, J. J., Isaacs, A., de Maat, M. P., Boersma, E., van Duijn, C. M., Akkerhuis, K. M., Uitterlinden, A. G., Witteman, J. C., Cambien, F., Ceconi, C., Remme, W., Bertrand, M., Ninomiya, T., Harrap, S., Chalmers, J., Macmahon, S., Fox, K., Ferrari, R., Simoons, M. L., & Danser, A. J. (2011). A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals. Journal of Hypertension, 29(3), 509-19. https://doi.org/10.1097/HJH.0b013e328341d117
    • Obermann-Borst, S. A., Isaacs, A., Younes, Z., van Schaik, R. H. N., van der Heiden, I. P., van Duyn, C. M., Steegers, E. A. P., & Steegers-Theunissen, R. P. M. (2011). General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect. American Journal of Obstetrics and Gynecology, 204(3), 236.e1-8. https://doi.org/10.1016/j.ajog.2010.10.911